Spero Therapeutics

SPRO

Börsenwert 68,1 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Anson Funds Management Dallas, Texas	5,03 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	2,36 Mio. $	-9.264 $	-6.905	-0,4 %
3	3 Acadian Asset Management Boston, Massachusetts	1,44 Mio. $	–	–	–
4	4 Renaissance Technologies New York	1,31 Mio. $	-1.743 $	-1.299	-0,1 %
5	5 Alphabet Inc Mountain View, California	1,19 Mio. $	–	–	–
6	6 ADAR1 Capital Management Austin, Texas	996.235 $	-235.411 $	-175.470	-19 %
7	7 BlackRock New York	649.660 $	+1.902 $	+1.418	+0,3 %
8	8 Geode Capital Management Boston, Massachusetts	644.939 $	-14.758 $	-11.000	-2 %
9	9 Novo Holdings A/S Hellerup, Denmark	628.329 $	–	–	–
10	10 Atlas Venture Life Science Advisors Cambridge, Massachusetts	539.866 $	-177.696 $	-132.451	-25 %
11	AIC 11 AWM Investment Company New York	446.756 $	–	–	–
12	12 Bridgeway Capital Management Houston, Texas	247.632 $	–	–	–
13	13 State Street Boston, Massachusetts	174.885 $	–	–	–
14	14 DAFNA Capital Management Los Angeles, California	167.500 $	–	–	–
15	15 Northern Trust Chicago, Illinois	149.406 $	-1.081 $	-806	-0,7 %
16	16 Citadel Advisors Miami, Florida	109.109 $	-309.385 $	-230.609	-74 %
17	17 Susquehanna International Group Bala Cynwyd, Pennsylvania	59.253 $	+28.369 $	+21.146	+92 %
18	18 Man Group London, United Kingdom	51.565 $	-46.940 $	-34.988	-48 %
19	19 Millennium Management New York	43.110 $	-89.010 $	-66.346	-67 %
20	20 Mackenzie Financial Toronto Ontario, Ontario, Canada	42.750 $	-1.108 $	-826	-3 %
21	21 DLK Investment Management Solana Beach, California	42.016 $	–	–	–
22	22 Three Seasons Wealth Salt Lake City, Utah	40.200 $	+20.124 $	+15.000	+100 %
23	23 Charles Schwab San Francisco, California	38.277 $	–	–	–
24	24 Shay Capital New York	33.500 $	–	–	–
25	25 UBS Group Zurich, Switzerland	23.489 $	+23.073 $	+17.198	+5.196 %

Spero Therapeutics SPRO Börsenwert 68,1 Mio. $

Spero Therapeutics

SPRO

Börsenwert 68,1 Mio. $